How to interpret blood glucose monitoring charts and adjust insulin doses
Interpreting blood glucose results and being able to adjust insulin doses are useful skills for pharmacists to possess.The key to acquiring these skills is in understanding:
- The insulin regimen and the onset, peak and duration of action for the insulins used
- The glucose levels to aim for
- How to titrate insulin doses
- How all of the above relates to patients’ lifestyles and eating habits
Understanding the regimen
Insulin may be given alone or, for those with type 2 diabetes, with oral antidiabetic drugs (OADs), often metformin. Although this article focuses on adjusting insulin doses, readers should bear in mind that oral doses may also need to be adjusted. The three most commonly used insulin regimens are:
- Once daily intermediate-acting or long-acting insulin — normally given at bedtime or during the day, usually with an OAD;
- Twice-daily pre-mixed insulin — one injection before breakfast, one before the evening meal (pre-mixed insulins contain fixed ratios of short- and long-acting insulins);
- Basal-bolus insulin — three daily injections of rapid- or short-acting insulin with meals and one or two injections of intermediate- or long-acting (basal) insulin.
The onset, peak and duration profiles of insulin products currentlyavailable in the UK are in the table. These should be used wheninterpreting a blood glucose result, to determine which insulin wasexerting its effect at the time of glucose measurement.
Insulin preparations and their onset, peak and duration of action
|Preparation||Onset (hr)||Peak (hr)||Duration (hr)|
|Hypurin Bovine Neutral||0.5/1||2–5||6–8|
|Apidra (Insulin glulisine)||0.25||1||3–4|
|Humalog (Insulin lispro)||0.25||1–1.5||2–5|
|Novorapid (Insulin aspart)||0.25||1–3||3–5|
|Hypurin Porcine Neutral||0.5/1||2–5||6–8|
|Human Mixtard 30||0.5||2–12||24|
|NovoMix 30||0.25||1–4||Up to 24 hrs|
|Humalog Mix 25||0.25||1–2||22|
|Humalog Mix 50||0.25||1–2||22|
|Hypurin Porcine 30/70||0.5||4–12||24|
|Insuman Comb 15||0.5||2–4||12–20|
|Insuman Comb 25||0.5||2–4||12–19|
|Insuman Comb 50||0.5||1–4||12–16|
|Hypurin Porcine Isophane||2||6–12||24|
|Hypurin Bovine Isophane||2||6–12||24|
Insulin zinc suspension (mixed)
|Hypurin Bovine Lente||2||8–12||30|
|Hypurin Bovine Protamine Zinc||4||10–20||36|
|Lantus (Insulin glargine)||2–4||No peak||20–24|
|Levemir (Insulin detemir)||2–4||6–14||16–20|
Glucose levels are usually recorded one to four times a day, depending on the stability of a patient’s condition. If carried out four times daily, glucose levels are usually measured before meals and at bedtime. The following levels are commonly recommended:
- Before breakfast (fasting level): 5.5–6.0mmol/L (with no nocturnal hypoglycaemia)
- Before lunch and before evening meal: 4.0–6.0mmol/L
- Before bed: 6.0–8.0mmol/L
If postprandial (after eating) insulin levels are being monitored, they should be taken two hours after each meal and aim to be less than 8.0mmol/L. Some patients may be set different targets (eg, those elderly patients who are prone to hypoglycaemia).
Altering the dose correctly
When reviewing a blood glucose chart, pharmacists should make a note of any levels that consistently fall outside the recommended target. One-off deviations can be ignored, although hypoglycaemia will usually need to be treated with glucose or glucagon.
Provided other causes can
be excluded (other causes include infection, which may raise glucose levels, or the consumption of large amounts of alcohol, which may lower levels a few hours later), practitioners should determine which insulin dose is responsible for persistently aberrant glucose levels. This requires the onset, peak and duration of action for each insulin that the patient is prescribed to be considered.
For example, if a patient is prescribed a twice-daily pre-mixed regimen, the morning dose of insulin is responsible for the patient’s pre-lunch and pre-evening meal glucose levels — the short-acting insulin affects the pre-lunch level and the longer-acting insulin affects the pre-evening meal level.
Avoiding common mistakes
The appropriate insulin dose should then be altered accordingly (see below). Once adjusted, the glucose monitoring chart needs to be reviewed over the following few days to ensure that the adjustment has altered the glucose levels appropriately.
Adjusting insulin doses
Insulin doses should be titrated slowly. A one-off, high glucose level is not likely to be problematic, however hypoglycaemia can be frightening for a patient to experience and may progress to a coma. Care in avoiding hypoglycaemia is the priority.
In most cases the following recommendations for adjusting insulin doses should be appropriate:
- Short- and rapid-acting insulin — adjust by no more than two units (or 10 per cent of the current dose) daily
- Intermediate-acting, long-acting and pre-mixed insulin — adjust by no more than two units, or 10 per cent (whichever is greater), every three to four days
If a patient is prescribed more than one type of insulin, adjust one type at a time. If patients are not in hospital while their insulin doses are being stabilised, practitioners may opt to telephone them at home and make recommendations based on glucose readings taken at home. However, many patients can be taught to self-manage, so should be encouraged to do so whenever possible. Some tips on avoiding common mistakes when dealing with diabetic patients are described the Panel.
The above recommendations are guidelines — each patient’s individual circumstances should be considered. Also, local policies and guidelines may differ slightly from these recommendations, so it is important to check these before adjusting insulin doses.
|Elizabeth Hackett is principal pharmacist for diabetes at University Hospitals of Leicester NHS Trust|
Reading this article counts towards your CPD
You can use the following forms to record your learning and action points from this article from Pharmaceutical Journal Publications.
Your CPD module results are stored against your account here at The Pharmaceutical Journal. You must be registered and logged into the site to do this. To review your module results, go to the ‘My Account’ tab and then ‘My CPD’.
Any training, learning or development activities that you undertake for CPD can also be recorded as evidence as part of your RPS Faculty practice-based portfolio when preparing for Faculty membership. To start your RPS Faculty journey today, access the portfolio and tools at www.rpharms.com/Faculty
If your learning was planned in advance, please click:
If your learning was spontaneous, please click:
Citation: Hospital Pharmacist URI: 10031318
Recommended from Pharmaceutical Press
Remington Education: Drug Information & Literature Evaluation teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature.£27.00Buy now